Notificação de entrada na fase nacional - PCT
#1.3
02/18/2026
RPI 2876
Application data
Number
112025012452Type
Filing
Publication
PCT
US2023084784 Examination has not been requested yet. Without that request by 12/19/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:12/19/2026(116 days left)
Latest action published by the INPI: 02/18/2026. We update with every new RPI gazette, published weekly.
Applicants
PRINCIPIA BIOPHARMA INC.
US
Inventors
C. V. (pessoa física)
US
M. C. (pessoa física)
US
IPC Classification
Priority claims
US
63/433,824 · 12/20/2022
Abstract
FORMULAÇÕES DE FÁRMACOS DE (R)-1-(1- ACRILOILPIPERIDIN-3-IL)-4-AMINO-3-(4-FENOXIFENIL)-1HIMIDAZO[4,5-C]PIRIDIN-2(3H)-ONA. A presente invenção refere-se ao campo dos inibidores terapêuticos da tirosina quinase de Bruton (BTK). São descritas formulações farmacêuticas de (R)-1-(1-acriloilpiperidin-3-il)-4-amino-3-(4-fenoxifenil)-1H-imidazo[4,5-c]piridin-2(3H)-ona.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
02/18/2026
RPI 2876
#1.1
07/22/2025
RPI 2846
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.